AtriCure to Pay $3.76M for Medicare Fraud Allegations

Medical device manufacturer AtriCure has agreed to pay $3.76 million to resolve civil Medicare fraud allegations that it marketed its medical devices to treat atrial fibrillation, According to according to the Justice Department, the use was not approved by the FDA.AtriCure manufactures surgical ablation devices, which use focused energy to create controlled lesions or scar tissue on the heart or other organs.

February 18, 2010

1 Min Read
AtriCure to Pay $3.76M for Medicare Fraud Allegations

According to the DOJ, AtriCure also allegedly promoted expensive heart surgery that used the company's devices when less invasive alternatives were appropriate, advised hospitals to up-code surgical procedures involving the company's products to inflate Medicare reimbursement and paid kickbacks to providers to use its devices, all in violation of the federal False Claims Act.The allegations against AtriCure were made in a lawsuit filed under the whistleblower provisions of the False Claims Act. The settlement was coordinated by the Justice Department's Civil Division, the U.S. Attorney's Office for the Southern District of Texas, HHS Office of the Inspector General and the FDA Office of Chief Counsel.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like